Q2 2024 · 13F-HR
Affinity Asset Advisors, LLCholdings as filed
Filed 2024-08-14 · accession 0001999371-24-010146
$867.5M
Reported value
98
Positions
2024-06-30
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78462F103 | SPY | SPDR S&P 500 ETF TR | $190.5M | 22.0% | 350,000 | PUT | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $38.8M | 4.47% | 994,227 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $32.9M | 3.79% | 836,283 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $30.8M | 3.55% | 110,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $25.4M | 2.93% | 460,000 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $23.6M | 2.72% | 1,450,000 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $23.1M | 2.66% | 515,000 | Common | SOLE |
| 15678U128 | CERE1EUR | CEREVEL THERAPEUTICS HLDNG I | $20.4M | 2.36% | 500,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $19.0M | 2.19% | 912,000 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $18.7M | 2.15% | 1,150,000 | CALL | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $17.6M | 2.03% | 475,400 | Common | SOLE |
| 10806XAB8 | BBIO 2.5 03/15/27 | BRIDGEBIO PHARMA INC | $17.3M | 1.99% | 17,000,000 | Common | SOLE |
| 02043QAB3 | ALNY 1 09/15/27 | ALNYLAM PHARMACEUTICALS INC | $16.2M | 1.87% | 15,000,000 | Common | SOLE |
| 07725L102 | ONC | BEIGENE LTD | $15.7M | 1.81% | 110,000 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $15.7M | 1.81% | 650,000 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $15.2M | 1.75% | 200,000 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $15.0M | 1.72% | 4,300,000 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $13.6M | 1.56% | 375,000 | Common | SOLE |
| 50127T109 | KURA | KURA ONCOLOGY INC | $13.4M | 1.54% | 650,000 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $12.7M | 1.47% | 2,856,252 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $12.1M | 1.39% | 513,420 | Common | SOLE |
| 28658R106 | CLYM | ELIEM THERAPEUTICS INC | $11.9M | 1.37% | 1,670,661 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $10.3M | 1.18% | 1,135,702 | Common | SOLE |
| 15678U128 | CERE1EUR | CEREVEL THERAPEUTICS HLDNG I | $10.2M | 1.18% | 250,000 | CALL | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $10.2M | 1.17% | 223,407 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $10.1M | 1.17% | 700,000 | Common | SOLE |
| 45332Y109 | NARIUSD | INARI MED INC | $9.6M | 1.11% | 200,000 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $9.1M | 1.05% | 346,088 | Common | SOLE |
| 04635X102 | CATBUSD | ASTRIA THERAPEUTICS INC | $8.9M | 1.02% | 975,606 | Common | SOLE |
| 19249HAB9 | — | COHERUS BIOSCIENCES INC | $8.6M | 1.00% | 11,750,000 | Common | SOLE |
| 61775R105 | MORFUSD | MORPHIC HLDG INC | $8.5M | 0.98% | 250,573 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $8.4M | 0.97% | 125,000 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $8.1M | 0.94% | 423,155 | Common | SOLE |
| 682143AG7 | OMER 5.25 02/15/26 | OMEROS CORP | $8.1M | 0.93% | 11,450,000 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $8.0M | 0.92% | 1,850,000 | Common | SOLE |
| N5749R100 | 2GH | MERUS N V | $7.4M | 0.85% | 125,000 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $6.4M | 0.74% | 80,000 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $6.4M | 0.73% | 1,500,000 | Common | SOLE |
| 48576UAA4 | — | KARYOPHARM THERAPEUTICS INC | $6.3M | 0.73% | 9,750,000 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $6.2M | 0.72% | 1,546,850 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $5.9M | 0.68% | 2,499,431 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $5.5M | 0.63% | 550,000 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $5.3M | 0.61% | 155,000 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $4.6M | 0.53% | 263,817 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $4.5M | 0.52% | 60,000 | Common | SOLE |
| 28623U101 | — | ELEVATION ONCOLOGY INC | $4.0M | 0.46% | 1,468,825 | Common | SOLE |
| 43157M102 | — | HILLEVAX INC | $3.8M | 0.44% | 265,859 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $3.8M | 0.44% | 327,959 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $3.7M | 0.43% | 351,587 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $3.5M | 0.41% | 100,000 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | $3.5M | 0.41% | 350,000 | Common | SOLE |
| N44445109 | IMTX | IMMATICS N.V | $3.5M | 0.40% | 300,000 | Common | SOLE |
| 78464A870 | XBI | SPDR SER TR | $3.5M | 0.40% | 37,550 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $3.2M | 0.37% | 1,619,140 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $3.0M | 0.35% | 650,000 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $3.0M | 0.35% | 500,512 | Common | SOLE |
| 68062P106 | OLMA | OLEMA PHARMACEUTICALS INC | $3.0M | 0.34% | 275,000 | Common | SOLE |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $2.8M | 0.33% | 521,000 | PUT | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $2.7M | 0.31% | 1,687,955 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $2.6M | 0.30% | 69,999 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $2.6M | 0.29% | 250,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $2.5M | 0.29% | 100,000 | Common | SOLE |
| 90184D100 | TWST | TWIST BIOSCIENCE CORP | $2.2M | 0.26% | 45,000 | CALL | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $2.0M | 0.22% | 150,000 | Common | SOLE |
| N62509117 | NAMSW | NEWAMSTERDAM PHARMA COMPANY | $1.9M | 0.22% | 202,599 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $1.9M | 0.22% | 375,000 | Common | SOLE |
| 92764N102 | VIR | VIR BIOTECHNOLOGY INC | $1.8M | 0.21% | 200,000 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $1.7M | 0.19% | 545,000 | PUT | SOLE |
| 98985Y108 | ZYME | ZYMEWORKS INC | $1.6M | 0.19% | 191,127 | Common | SOLE |
| 359616109 | FULC | FULCRUM THERAPEUTICS INC | $1.6M | 0.18% | 250,000 | CALL | SOLE |
| 59045L106 | — | MERSANA THERAPEUTICS INC | $1.5M | 0.18% | 767,000 | Common | SOLE |
| G31659108 | — | ARYA SCIENCES ACQU CORP IV | $1.5M | 0.18% | 133,500 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $1.5M | 0.17% | 474,744 | Common | SOLE |
| 501976104 | KYTX | KYVERNA THERAPEUTICS INC | $1.5M | 0.17% | 200,000 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $1.4M | 0.17% | 54,300 | CALL | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $1.3M | 0.15% | 50,000 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $1.3M | 0.15% | 150,274 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $1.2M | 0.14% | 150,000 | PUT | SOLE |
| 65487U108 | NKTX | NKARTA INC | $1.2M | 0.14% | 200,000 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $1.1M | 0.13% | 15,000 | CALL | SOLE |
| 49372L100 | — | KEZAR LIFE SCIENCES INC | $1.1M | 0.12% | 1,761,778 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $960,712 | 0.11% | 58,331 | Common | SOLE |
| 74587V107 | PBYI | PUMA BIOTECHNOLOGY INC | $815,000 | 0.09% | 250,000 | Common | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $781,673 | 0.09% | 223,335 | Common | SOLE |
| 00166B105 | ALXO | ALX ONCOLOGY HLDGS INC | $603,000 | 0.07% | 100,000 | CALL | SOLE |
| 457669307 | INSM | INSMED INC | $582,900 | 0.07% | 8,700 | PUT | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $561,150 | 0.06% | 45,000 | Common | SOLE |
| 746964105 | QTTB | Q32 BIO INC | $498,597 | 0.06% | 27,777 | Common | SOLE |
| N44445117 | IMTXW | IMMATICS N.V | $484,858 | 0.06% | 187,204 | Common | SOLE |
| 64132R404 | — | NEUROBO PHARMACEUTICALS IN | $431,834 | 0.05% | 89,222 | Common | SOLE |
| 74346M406 | PMNEUR | PROMIS NEUROSCIENCES INC | $398,937 | 0.05% | 265,958 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $332,000 | 0.04% | 200,000 | Common | SOLE |
| 00211Y506 | ABIOEUR | ARCA BIOPHARMA INC | $277,614 | 0.03% | 72,484 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $228,750 | 0.03% | 75,000 | Common | SOLE |
| 702712100 | — | PASSAGE BIO INC | $209,880 | 0.02% | 264,266 | Common | SOLE |
| 36870H103 | GNLX | GENELUX CORPORATION | $195,000 | 0.02% | 100,000 | Common | SOLE |
| 77313F114 | RCKTW | ROCKET PHARMACEUTICALS INC | $4,523 | 0.00% | 75,000 | Common | SOLE |
| 462260100 | IOVA | IOVANCE BIOTHERAPEUTICS INC | $802 | 0.00% | 100 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.